Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program

ER (Eric) Manusama; PTGA Nooijen; Timo ten Hagen; AH Veen; MWR de Vries; JHW Wilt; MG IJken; RL (Richard) Marquet; Lex Eggermont

Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program

ER (Eric) Manusama, PTGA Nooijen, Timo ten Hagen, AH Veen, MWR de Vries, JHW Wilt, MG IJken, RL (Richard) Marquet, Lex Eggermont

Surgery

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	232-237
Number of pages	6
Journal	Seminars in Surgical Oncology
Volume	14
Publication status	Published - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c591092a32ab4e2eb54ef280dd87b2fd,

title = "Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program",

author = "Manusama, {ER (Eric)} and PTGA Nooijen and {ten Hagen}, Timo and AH Veen and {de Vries}, MWR and JHW Wilt and MG IJken and Marquet, {RL (Richard)} and Lex Eggermont",

year = "1998",

language = "Undefined/Unknown",

volume = "14",

pages = "232--237",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program

AU - Manusama, ER (Eric)

AU - Nooijen, PTGA

AU - ten Hagen, Timo

AU - Veen, AH

AU - de Vries, MWR

AU - Wilt, JHW

AU - IJken, MG

AU - Marquet, RL (Richard)

AU - Eggermont, Lex

PY - 1998

Y1 - 1998

M3 - Article

SN - 0022-4790

VL - 14

SP - 232

EP - 237

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

ER -